Fluidigm , Nasdaq: FLDM
Makes high-throughput sequencing devices and consumables for genetic labs.
Industry: Health Care
First Day Return: +3.9%
FLDM
Makes high-throughput sequencing devices and consumables for genetic labs.
| IPO Data | |
|---|---|
| IPO Date | 02/09/2011 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $75 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | South San Francisco, CA, United States |
| Founded | 1999 |
| Employees at IPO | 198 |
| Website www.fluidigm.com | |
IPO News for Fluidigm
Fluidigm (FLDM) Performance
